Handelsbanken Fonder AB Has $1.46 Million Stock Holdings in Teleflex Incorporated $TFX

Handelsbanken Fonder AB decreased its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 7.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,300 shares of the medical technology company’s stock after selling 1,000 shares during the period. Handelsbanken Fonder AB’s holdings in Teleflex were worth $1,456,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Cetera Investment Advisers bought a new position in shares of Teleflex during the 1st quarter worth approximately $206,000. Empirical Finance LLC lifted its position in shares of Teleflex by 7.9% during the 1st quarter. Empirical Finance LLC now owns 1,690 shares of the medical technology company’s stock valued at $234,000 after acquiring an additional 124 shares during the period. LPL Financial LLC boosted its stake in Teleflex by 15.6% during the first quarter. LPL Financial LLC now owns 40,365 shares of the medical technology company’s stock worth $5,578,000 after acquiring an additional 5,434 shares in the last quarter. Mackenzie Financial Corp grew its holdings in Teleflex by 45.1% in the first quarter. Mackenzie Financial Corp now owns 52,651 shares of the medical technology company’s stock worth $7,276,000 after purchasing an additional 16,370 shares during the period. Finally, Banque Cantonale Vaudoise bought a new stake in Teleflex in the first quarter valued at $27,000. 95.62% of the stock is currently owned by institutional investors.

Teleflex Stock Performance

Shares of Teleflex stock opened at $115.60 on Thursday. Teleflex Incorporated has a 52 week low of $102.58 and a 52 week high of $195.24. The company has a quick ratio of 1.44, a current ratio of 2.41 and a debt-to-equity ratio of 0.42. The business has a 50 day moving average price of $120.69 and a 200-day moving average price of $121.24. The company has a market cap of $5.11 billion, a PE ratio of 27.20, a price-to-earnings-growth ratio of 1.79 and a beta of 1.05.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.38 by $0.29. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The company had revenue of $892.90 million for the quarter, compared to analysts’ expectations of $892.79 million. Teleflex’s quarterly revenue was up 19.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. Equities analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Stockholders of record on Friday, November 14th will be issued a $0.34 dividend. The ex-dividend date is Friday, November 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.2%. Teleflex’s dividend payout ratio is currently -18.50%.

Analysts Set New Price Targets

A number of research firms have recently issued reports on TFX. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research report on Tuesday. Royal Bank Of Canada dropped their price target on Teleflex from $135.00 to $120.00 and set a “sector perform” rating on the stock in a research note on Friday, November 7th. Wall Street Zen cut Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Zacks Research downgraded Teleflex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 30th. Finally, Truist Financial lowered their target price on Teleflex from $128.00 to $120.00 and set a “hold” rating on the stock in a research report on Monday, November 10th. One research analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus price target of $134.57.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.